Multiple System Atrophy (MSA) Market ANALISI DIMENSIONE E QUOTA - TENDENZE DI CRESCITA E PREVISIONI (2024 - 2031)

Multiple System Atrophy (MSA) Market is Segmented By Subtype (MSA-Parkinsonian, MSA-Cerebellar), By Diagnosis (Clinical Diagnosis, Biomarker-Based Diagnosis, Imaging-Based Diagnosis), By Treatment (Pharmacological Therapies, Non-Pharmacological Therapies), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.

Multiple System Atrophy (MSA) Market Leaders

  • Chelsea Therapeutics International, Ltd.
  • Biohaven Farmaceutici, Inc.
  • Sumitomo Dainippon Pharma Co., Ltd.
  • AstraZeneca pl
  • Theravance Biopharma, Inc.
*Disclaimer: Major players are listed in no particular order.

Multiple System Atrophy (MSA) Market - Company List

  • Chelsea Therapeutics International, Ltd.
  • Biohaven Farmaceutici, Inc.
  • Sumitomo Dainippon Pharma Co., Ltd.
  • AstraZeneca pl
  • Theravance Biopharma, Inc.
  • Merck & Co.
  • Neuropore Therapies Inc.
  • Newron Farmaceutici SpA
  • ProMIS Neurosciences Inc.
  • Bioterapeutica della sterilità Corp.
  • AFFiRiS AG
  • Corestem Inc.
  • MitoDys Therapeutics Ltd.
  • Modag GmbH
  • Acadia Farmaceutica Inc.
  • Novartis AG
  • Sanofi S.A.
  • Teva Farmaceutica Industries Ltd.
  • Eli Lilly e Company
  • Johnson & Johnson

Multiple System Atrophy (MSA) Market Report Snapshots

Buy Now